Las Vegas Sun

June 1, 2012

Currently: 102° | Complete forecast | Log in

Wyeth reveals probe

Tuesday, Feb. 11, 2003 | 9:49 a.m.

MADISON, N.J. -- Wyeth today said it expects a subpoena from the U.S. Justice Department for an inquiry into allegations of "collusive" sales practices with another drugmaker.

The company, whose hormone replacement treatments were tied to cancer and heart risks last year, made the disclosure in a regulatory filing and said the allegations are related to commissions for a "small segment of the over-the-counter drug business." The filing didn't name another pharmaceutical company.

archive